scholarly journals Clinical efficacy of icotinib in patients with advanced nonsquamous non-small cell lung cancer with unknown EGFR mutation status that failed to respond to second-line chemotherapy

2018 ◽  
Vol 6 (20) ◽  
pp. 405-405 ◽  
Author(s):  
Lu Xu ◽  
Xin-Hua Xu ◽  
Cheng Yuan ◽  
Jia-Yu Zhang ◽  
Xi Tang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Clinical Efficacy ◽  
Cell Lung Cancer ◽  
Egfr Mutation ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Mutation Status ◽  
Line Chemotherapy

Second-Line Chemotherapy with a Modified Schedule of Docetaxel in Elderly Patients with Advanced-Stage Non-Small-Cell Lung Cancer

2006 ◽  
Vol 7 (6) ◽  
pp. 401-405 ◽  
Author(s):  
Carmelo Tibaldi ◽  
Ilaria Bernardini ◽  
Antonio Chella ◽  
Francesa Russo ◽  
Enrico Vasile ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Stage ◽  
Second Line ◽  
Small Cell Lung ◽  
Line Chemotherapy ◽  
Modified Schedule

Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy

2021 ◽  
pp. canres.CAN-21-2964-E.2021
Author(s):  
Alvaro Quintanal-Villalonga ◽  
Hirokazu Taniguchi ◽  
Yuan Hao ◽  
Andrew Chow ◽  
Yingqian A Zhan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document